Observational Study
Copyright ©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1263-1271
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1263
Table 1 Clinical characteristics of study participates by quartiles of hemoglobin A1c
Variables
HbA1c quartiles
P value
Q1 (< 7.875), n = 32
Q2 (7.875-9.050), n = 33
Q3 (9.050-11.200), n = 32
Q4 (≥ 11.200), n = 33
Age (yr)63.5 ± 13.360.9 ± 9.759.5 ± 16.160.2 ± 13.00.640
Sex (male/female)18/14 (56.3/43.8)16/17 (48.5/51.5)20/12 (62.5/37.5)21/12 (63.6/36.4)0.582
Diabetes duration (yr)6.5 (3.0, 17.5)10 (6.5, 15.0)8.0 (1.3, 19.8)5.0 (1.0, 12.0)0.173
Height (cm)165.6 ± 8.1164.2 ± 8.8166.8 ± 9.0167.4 ± 6.60.392
Weight (cm)71.5 ± 11.570.9 ± 11.473.8 ± 18.371.4 ± 8.70.803
BMI (kg/m2)26.1 ± 3.726.2 ± 3.326.2 ± 4.525.4 ± 2.50.772
Neck line (cm)39.1 ± 3.538.2 ± 3.838.3 ± 4.038.4 ± 2.40.731
Waist line (cm)97.3 ± 8.995.0 ± 10.294.5 ± 11.194.7 ± 8.50.646
Hip line (cm)103.5 ± 8.3102.1 ± 8.8100.3 ± 9.7100.9 ± 8.70.492
WHR0.94 ± 0.050.93 ± 0.040.94 ± 0.050.94 ± 0.040.698
SBP (mmHg)132.8 ± 21.2139.1 ± 17.5132.6 ± 20.3134.3 ± 16.20.474
DBP (mmHg)77.2 ± 9.080.0 ± 8.278.3 ± 9.080.3 ± 8.00.415
mALB (g/L)11.0 (11.0, 41.5)11.0 (10.5, 50.0)32.5 (12.0, 123.5)20.0 (12.5, 53.5)0.031
TC (mmol/L)4.46 ± 1.014.70 ± 1.114.81 ± 1.295.00 ± 1.350.321
TG (mmol/L)1.54 (1.04, 2.32)2.17 (1.10, 2.93)1.81 (1.37, 3.83)1.37 (0.84, 2.28)0.044
HDL-C (mmol/L)1.25 ± 0.371.11 ± 0.321.10 ± 0.311.14 ± 0.310.274
LDL-C (mmol/L)2.83 ± 1.103.02 ± 1.022.89 ± 0.883.51 ± 1.150.037
HOMA-IR3.09 (1.69, 4.48)4.59 (3.07, 7.12)6.05 (4.34, 10.41)6.06 (3.62, 8.14)< 0.001
HOMA-β80.15 (35.79, 131.06)38.55 (21.90, 73.18)53.04 (22.48, 96.73)21.70 (10.86, 45.92)0.001
Complicated with hypertension (%)17 (53.1)21 (63.6)17 (53.1)18 (54.5)0.796
Complicated with CHD (%)20 (62.5)18 (54.5)23 (71.9)18 (54.5)0.429